The PDA/FDA Joint Regulatory Conference is celebrating its 33rd year of informing, educating, and guiding industry professionals and organizations. This CGMP conference emphasizes the role of effective quality systems in ensuring an ongoing state of control throughout the product lifecycle by diligently managing risks to manufacturing and quality.
The vital role of robust quality systems, facilities, processes, raw material quality, supplier relationships, industrial modernization, and quality risk management are emphasized as fundamental to assuring Current Good Manufacturing Practice (CGMP) compliance.
Case studies presented throughout the conference will provide practical insights and illustrate how sustainable compliance establishes the foundation for quality and supply consistency. International collaboration efforts to improve quality and benefit consumers will also be highlighted.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze